If someone used to fill up eating a great deal of food, and now they fill up eating a lot less, t hey will lose weight
Hiding in plain sight: modern thiamine deficiency
Cardiovascular benefit of oral semaglutide in patients with T2DM and established atherosclerotic cardiovascular diseases and/or chronic kidney disease is currently under investigation in SOUL (Semaglutide cardiovascular outcomes) trial (45)
In this context, GLP-1R agonists show remarkable potential as an emerging therapeutic agent.GLP-1R agonists reduce body weight, lower blood pressure, and improve lipid levels, as well as exerting anti-inflammatory and antioxidant effects by directly acting on GLP-1R in the heart and blood vessels, thereby reducing the risk of atherosclerotic thrombotic events (Solini et al., 2023)
This loss of equilibrium in drug abusers may increase risk of metabolic dysfunctions which may result in worsening addiction and possible disease states such as those manifested as the metabolic syndrome
3,4 Berberine, for instance, frequently labeled as "nature's Ozempic," has gained popularity through anecdotal claims of weight reduction and improved glycemic control